Stock Events

ProShares UltraShort Nasdaq Biotechnology -2x Shares 

$15.04
8
-$0.17-1.11% Monday 20:00

Statistics

Day High
15.34
Day Low
15.04
52W High
26.51
52W Low
14.05
Volume
822
Avg. Volume
13,454
Mkt Cap
-
P/E Ratio
-
Dividend Yield
4.31%
Dividend
0.65

Upcoming

2
OCT
Dividend Payment
Decreased
 
23
DEC
Dividend Ex
Estimated
 
31
DEC
Dividend Payment
Estimated
 
20
MAR 25
Dividend Ex
Estimated
 
27
MAR 25
Dividend Payment
Estimated
 
26
JUN 25
Dividend Ex
Estimated
 
3
JUL 25
Dividend Payment
Estimated
 
25
SEP 25
Dividend Ex
Estimated
 
2
OCT 25
Dividend Payment
Estimated
 
20
DEC 25
Dividend Ex
Estimated
 

Dividends

4.31%Dividend Yield
Oct 24
$0.15
Jul 24
$0.16
Mar 24
$0.16
Dec 23
$0.18
Sep 23
$0.12
10Y Growth
N/A
5Y Growth
18.05%
3Y Growth
N/A
1Y Growth
104.94%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BIS. It's not an investment recommendation.
Alphabet
74483
GOOGL
Apple
64892
AAPL
Microsoft
60484
MSFT
Amazon
55828
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Direxion Daily S&P Biotech Bear 3X Shares
LABD
Mkt Cap0
Direxion Daily S&P Biotech Bear 3X Shares, offers 3x inverse exposure to an index of US biotechnology stocks, competing directly with BIS's inverse biotech focus.
ProShares UltraShort MSCI Brazil Capped -2x Shares
BZQ
Mkt Cap0
ProShares UltraShort MSCI Brazil Capped, offers -2x exposure to Brazilian stocks, including biotech, competing in the inverse ETF space.
ProShares UltraShort QQQ -2x Shares
QID
Mkt Cap0
ProShares UltraShort QQQ, offers -2x exposure to the NASDAQ-100 Index, competing by targeting a similar index but broader than just biotech.
ProShares UltraPro Short QQQ -3x Shares
SQQQ
Mkt Cap0
ProShares UltraPro Short QQQ, offers -3x exposure to the NASDAQ-100, directly competing in the inverse market with a focus on tech, including biotech.
Zenas Biopharma
ZBIO
Mkt Cap3.51M
ProShares UltraPro Short NASDAQ Biotechnology, offers -3x exposure to the NASDAQ Biotechnology Index, a direct competitor with a higher leverage point.
Direxion Daily S&P Biotech Bull 3X Shares
LABU
Mkt Cap0
Direxion Daily S&P Biotech Bull 3X Shares, the bullish counterpart to LABD, competes by offering the opposite investment strategy in the same sector.
VanEck Biotech
BBH
Mkt Cap0
VanEck Vectors Biotech ETF, offers exposure to biotech stocks, competing as a non-leveraged alternative in the biotech investment space.
iShares Biotechnology
IBB
Mkt Cap0
iShares Biotechnology ETF, provides exposure to a similar biotech index, competing as a more traditional, non-leveraged investment option.
SPDR Biotech
XBI
Mkt Cap0
SPDR S&P Biotech ETF, competes by offering exposure to the biotech sector in a non-leveraged format, appealing to a different risk profile.
ALPS Medical Breakthroughs
SBIO
Mkt Cap0
ALPS Medical Breakthroughs ETF, competes by focusing on small- to mid-cap biotechnology and medical research companies, offering a different take on the biotech sector.

About

Miscellaneous
Investment Trusts/Mutual Funds
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
Show more...
CEO
Country
US
ISIN
US74347G8380

Listings

XNAS
US
BIS